Prostaglandin receptors mediate effects of substances released from ischaemic rat hearts on non-ischaemic cardiomyocytes

European Journal of Clinical Investigation

Volumn 38, Issue 12, 2008, Pages 902-909

  Birkenmeier, K ^b   Janke, I ^b   Schunck, W H ^c   Trimpert, C ^b   Krieg, T ^b   Landsberger, M ^b   Volker U ^b   Felix, S B ^a,b   Staudt, A ^a,b  

^a Unversitätsmedizin Greifswald   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Cardiodepressive mediators; Ischaemia reperfusion; Prostaglandin receptors; Protein kinase A

Indexed keywords

CYCLIC AMP; CYCLOOXYGENASE 2; PROSTAGLANDIN D RECEPTOR; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN I RECEPTOR; PROSTAGLANDIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM METABOLISM; CELL LYSATE; CONTROLLED STUDY; CORONARY ARTERY; FLUORESCENCE MICROSCOPY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; INOTROPISM; ISOLATED HEART; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOOXYGENASE INHIBITORS; HEART; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCYTES, CARDIAC; PROTEIN KINASE C; RATS; RATS, WISTAR; RECEPTORS, PROSTAGLANDIN;

EID: 56649124493     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2008.02052.x     Document Type: Article

References (44)

1. Birkenmeier K, Staudt A, Schunck WH, Janke I, Labitzke C, Prange T et al. COX-2-dependent and potentially cardioprotective effects of negative inotropic substances released after ischemia. Am J Physiol Heart Circ Physiol 2007 293 : 2148 54.
2. Felix SB, Stangl V, Pietsch P, Bramlage P, Staudt A, Bartel S et al. Soluble substances released from postischemic reperfused rat hearts reduce calcium transient and contractility by blocking the L-type calcium channel. J Am Coll Cardiol 2001 37 : 668 75.
3. Felix SB, Stangl V, Frank TM, Harms C, Staudt A, Berndt T et al. Release of a stable cardiodepressant mediator after myocardial ischaemia during reperfusion. Cardiovasc Res 1997 35 : 68 79.
4. 2 induces vascular relaxation by E-prostanoid 4 receptor-mediated activation of endothelial nitric oxide synthase. Hypertension 2007 50 : 525 30.
5. 2 in acetylcholine-induced positive inotropy in isolated mouse left atria. Pharmacology 2003 67 : 157 62.
6. Xiao CY, Yuhki K, Hara A, Fujino T, Kuriyama S, Yamada T et al. Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4. Circulation 2004 109 : 2462 8.
7. Martin M, Meyer-Kirchrath J, Kaber G, Jacoby Ch, Flögel U, Schrader J et al. Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury. Circulation 2005 112 : 400 6.
8. Kuzumoto Y, Sho M, Ikeda N, Mizuno T, Hamada K, Akashi S et al. Role of EP4 prostaglandin E2 receptor in the ischemic liver. Transplant Proc 2005 37 : 422 4.
9. 1-Adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes. Eur J Pharmacol 2003 466 : 1 6.
10. Eichholtz T, de Bonte DBA, de Widt J, Liskamp RMJ, Ploegh HL. A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor. J Biol Chem 1993 268 : 1982 6.
11. Zhao H, Usui H, Ohinata K, Yoshikawa M. Met-Arg-Trp derived from Rubisco lowers blood pressure via prostaglandin D(2)-dependent vasorelaxation in spontaneously hypertensive rats. Peptides 2008 29 : 345 9.
12. + ATPase activity via PGE2 and EP2 receptors. Prostaglandins Other Lipid Med 2007 83 : 295 303.
13. Ma X, Kundu N, Rifat S, Walser T, Fulton AM. Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis. Cancer Res 2006 66 : 2923 7.
14. Clark RD, Jahangir A, Severance D, Salazar R, Chang T, Chang D et al. Discovery and SAR development of 2-(phenylamino) imidazolines as prostacyclin receptor antagonists. Bioorg Med Chem Lett 2004 14 : 1053 6.
15. Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004 56 : 387 437.
16. Nagata K, Hirai H. The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. Prostaglandins Leukot Essent Fatty Acids 2003 69 : 169 77.
17. Wang X, Klein RD. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway. Mol Carcinog 2007 46 : 912 23.
18. 2 receptor. Circulation 2005 112 : 84 92.
19. Chen J, Capdevila JH, Zeldin DC, Rosenberg RL. Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids. Mol Pharmacol 1999 55 : 288 95.
20. Sato H, Bolli R, Rokosh GD, Bi Q, Dai S, Shirk G et al. The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats. Am J Physiol Heart Circ Physiol 2007 293 : 2557 64.
21. Schrör K. Eicosanoids and myocardial ischemia. Basic Res Cardiol 1987 82 : 235 43.
22. Shinmura K, Tang XL, Wang Y, Xuan YT, Liu SQ, Bhatnagar A et al. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA 2000 97 : 10 197 202.
23. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994 46 : 205 29.
24. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999 79 : 1193 226.
25. Adderley SR, Fitzgerald DJ. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2;-mediated induction of cyclooxygenase-2. J Biol Chem 1999 274 : 5038 46.
26. Ishikawa T, Morris PL. Interleukin-1β signals through a c-Jun N-terminal kinase-dependent inducible nitric oxide synthase and nitric oxide production pathway in Sertoli epithelial cells. Endocrinology 2006 147 : 5424 30.
27. Norvell SM, Ponik SM, Bowen DK, Gerard R, Pavalko FM. Fluid shear stress induction of COX-2 protein and prostaglandin release in cultured MC3T3-E1 osteoblasts does not require intact microfilaments or microtubules. J Appl Physiol 2004 96 : 957 66.
28. Oh PS, Lee SJ, Lim KT. Glycoprotein isolated from Rhus verniciflua Stokes inhibits inflammation-related protein and nitric oxide production in LPS-stimulated RAW 264.7 cells. Biol Pharm Bull 2007 30 : 111 6.
29. 2 and the receptor Ep4 in osteoblasts. Life Sci 2006 78 : 2012 8.
30. 4 receptor subtypes. J Leukoc Biol 2003 73 : 756 63.
31. 3 receptor. Am J Physiol Heart Circ Physiol 2005 288 : 2093 101.
32. Klein AL, Wold LE, Ren J. The cyclooxygenase-2 product prostaglandin E2 modulates cardiac contractile function in adult rat ventricular cardiomyocytes. Pharmacol Res 2004 49 : 99 103.
33. Auclair MC, Vernimmen C, Lechat P. Influence of prostacyclin and two metabolites on the contractility of cultured rat heart cells. Prostaglandins Leukot Essent Fatty Acids 1988 32 : 33 8.
34. Hattori Y, Levi R. Effect of PGD2 on cardiac contractility: a negative inotropism secondary to coronary vasoconstriction conceals a primary positive inotropic action. J Pharmacol Exp Ther 1986 237 : 719 24.
35. Hohlfeld T, Meyer-Kirchrath J, Vogel YC, Schrör K. Reduction of infarct size by selective stimulation of prostaglandin EP(3)receptors in the reperfused ischemic pig heart. J Mol Cell Cardiol 2000 32 : 285 96.
36. Liu D, Wu L, Breyer R, Mattson MP, Andreasson K. Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia. Ann Neurol 2008 63 : 758 61.
37. Choi S, Yeum OH, Chang IY, You HJ, Park JS, Jeong HS et al. Activating of ATP-dependent K+ channels comprised of K(ir) 6.2 and SUR 2B by PGE2 through EP2 receptor in cultured interstitial cells of Cajal from murine small intestine. Cell Physiol Biochem 2006 18 : 187 98.
38. 3 receptor reduces myocardial infarct size in rodents. Arterioscler Thromb Vase Biol 1999 19 : 2141 7.
39. 2- Adrenergic receptor agonists stimulate L-type calcium current independent of PKA in newborn rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol 2007 293 : 2826 35.
40. Layland J, Grieve DJ, Cave AC, Sparks E, Solaro RJ, Shah AM. Essential role of troponin I in the positive inotropic response to isoprenaline in mouse hearts contracting auxotonically. J Physiol 2004 556 : 835 47.
41. 2-adrenoceptors agonists in guinea-pig right papillary muscles. Am J Physiol Cell Physiol 2008 18 : 710 5.
42. Wellman GC, Quayle JM, Standen NB. ATP-sensitive K+ channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle. J Physiol 1998 15 : 117 29.
43. Xu H, Wang Y, Tao J, Yang C, Chen J, Wang H et al. The cardioprotective peptide, urocortin, activates cardiac KATP channels in adult rat. Protein Pept Lett 2006 13 : 21 7.
44. Sanada S, Asanuma H, Tsukamoto O, Minamino T, Node K, Takashima S et al. Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C. Circulation 2004 110 : 51 7.